We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Highwoods Properties
HIW
$3.65B
| $48.7M | 0.26% |
+1,567,478
| New | +$46.1M |
|
102
Madrigal Pharmaceuticals
MDGL
$10.8B
| $48.3M | 0.26% |
159,623
-157,810
| -50% | -$47M |
|
103
STAG Industrial
STAG
$7.38B
| $48.3M | 0.26% |
+1,331,504
| New | +$46M |
|
104
CubeSmart
CUBE
$9.39B
| $48.3M | 0.26% |
+1,136,397
| New | +$47.1M |
|
105
Costco
COST
$422B
| $47.5M | 0.25% |
47,993
+10,491
| +28% | +$10.4M |
|
106
Arista Networks
ANET
$227B
| $47.4M | 0.25% |
+463,281
| New | +$40.1M |
|
107
EastGroup Properties
EGP
$11.2B
| $47.4M | 0.25% |
+283,354
| New | +$47.1M |
|
108
Ryan Specialty Holdings
RYAN
$5.72B
| $47.1M | 0.25% |
692,858
+147,604
| +27% | +$10.2M |
|
|
AIRO
109
AIRO Group Holdings
AIRO
$212M
| $47M | 0.25% |
+1,952,611
| New | +$49.5M |
|
110
Union Pacific
UNP
$174B
| $46.1M | 0.24% |
200,458
+172,450
| +616% | +$38.3M |
|
111
Pultegroup
PHM
$24.1B
| $46.1M | 0.24% |
436,952
+211,512
| +94% | +$21.3M |
|
112
Disc Medicine
IRON
$2.96B
| $45.9M | 0.24% |
866,955
+364,725
| +73% | +$17.1M |
|
113
Walmart Inc
WMT
$885B
| $45.7M | 0.24% |
467,351
+100,852
| +28% | +$9.61M |
|
114
Elanco Animal Health
ELAN
$13.2B
| $45.5M | 0.24% |
+3,189,185
| New | +$37.3M |
|
115
Equitable Holdings
EQH
$13B
| $45.2M | 0.24% |
+806,464
| New | +$41.5M |
|
116
Bristol-Myers Squibb
BMY
$133B
| $45.2M | 0.24% |
976,360
-315,255
| -24% | -$15.5M |
|
117
Roivant Sciences
ROIV
$24.5B
| $45.1M | 0.24% |
4,000,033
-1,253,323
| -24% | -$13.6M |
|
118
Paychex
PAYX
$41.6B
| $45M | 0.24% |
309,178
+287,575
| +1,331% | +$43.3M |
|
119
Procore
PCOR
$8.26B
| $44.9M | 0.24% |
655,546
+564,690
| +622% | +$36.9M |
|
120
Assurant
AIZ
$13.8B
| $44.3M | 0.23% |
+224,459
| New | +$44.1M |
|
121
Lennox International
LII
$14.4B
| $44.3M | 0.23% |
+77,295
| New | +$43.2M |
|
122
BorgWarner
BWA
$13.1B
| $43.9M | 0.23% |
1,311,110
+754,186
| +135% | +$23.1M |
|
123
Zimmer Biomet
ZBH
$18.2B
| $43.9M | 0.23% |
480,830
+326
| +0.1% | +$31.5K |
|
124
Mastercard
MA
$502B
| $43.4M | 0.23% |
77,301
+8,497
| +12% | +$4.7M |
|
125
Trex
TREX
$4.51B
| $43.4M | 0.23% |
798,641
+59,589
| +8% | +$3.38M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.